Inhibition of Ca2+-activated K+ current by clotrimazole in rat anterior pituitary GH3 cells

Neuropharmacology

Volumn 38, Issue 7, 1999, Pages 979-989

  Wu, Sheng Nan ^a   Li, Hui Fan ^a   Jan, Chung Ren ^a   Shen, Ai Yu ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

Author keywords

Clotrimazole; GH3 cells; K+ channel

Indexed keywords

ANTIFUNGAL AGENT; CALCIUM ION; CLOTRIMAZOLE; CYTOCHROME P450; ECONAZOLE; KETOCONAZOLE; POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ARTICLE; CELL STRAIN GH3; CONTROLLED STUDY; DRUG EFFECT; HORMONE RELEASE; ION CONDUCTANCE; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; ACTION POTENTIAL; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; HYPOPHYSIS; METABOLISM;

ACTION POTENTIALS; ANIMALS; ANTIFUNGAL AGENTS; CALCIUM CHANNELS; CELLS, CULTURED; CLOTRIMAZOLE; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; PITUITARY GLAND; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS;

EID: 0032586871     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00027-1     Document Type: Article

References (35)

1. + channels by cytochrome P-450 inhibitors. J. Biol. Chem. 267:1992;11789-11793.
2. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 92:1993;520-526.
3. + channel: the imidazole ring is not required for inhibitory activity. J. Pharmacol. Exp. Ther. 273:1995;266-272.
4. Chan S.L., Pallett A.L., Morgan N.G. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets. Naunyn-Schmied. Arch. Pharmacol. 356:1997;763-768.
5. Coupry L., Armsby C.C., Alper S.L., Brugnara C., Parini A. Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline II and I2 binding sites. Eur. J. Pharmacol. 295:1996;109-112.
6. De Franceschi L., Rouyer-Fessard P., Alper S.L., Jousault H., Brugnara C., Beuzard Y. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a b-thalassemic mouse: a model for human therapy. Blood. 87:1996;1188-1195.
7. + channels. Am. J. Physiol. 273:1997;C531-C540.
8. Ca channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid. Neuropharmacology. 35:1996;949-961.
9. Edwards G., Zygmunt P.M., Högestätt E.D., Weston A.H. Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein. Br. J. Pharmacol. 119:1996;691-701.
10. Halpert J.R. Structural basis of selective cytochrome P-450 inhibition. Annu. Rev. Pharmacol. Toxicol. 35:1995;29-53.
11. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
12. +-activated potassium channels in human leukaemic T lymphocytes. J. Physiol. 496:1996;627-637.
13. Hatton C.J., Peers C. Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells. Am. J. Physiol. 271:1996;C85-C92.
14. Horn R., Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J. Gen. Physiol. 92:1988;145-159.
15. Ishii T.M., Silvia C., Hirschberg B., Bond C.T., Adelman J.P., Maylie J. A human intermediate conductance calcium-activated potassium channel. Proc. Natl. Acad. Sci. USA. 94:1997;11651-11656.
16. + channel. Am. J. Physiol. 275:1998;C848-C856.
17. Joiner W.J., Wang L.Y., Tang M.D., Kaczmarek L.K. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc. Natl. Acad. Sci. USA. 94:1997;11013-11018.
18. + channels in rat lactotrophs: reversal by long-term exposure to dopamine agonist. Endocrinology. 138:1997;3141-3153.
19. + channels in a pituitary cell line. J. Physiol. 425:1990;117-132.
20. Latorre R., Oberhauser A., Labarca P., Alvarez O. Varieties of calcium-activated potassium channels. Annu. Rev. Physiol. 51:1989;385-399.
21. Logsdon N.J., Kang J., Togo J.A., Christian E.P., Aiyar J. A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J. Biol. Chem. 272:1997;32723-32726.
22. Olmos G.R., Kulkarni R.N., Haque M., MacDermont J. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Eur. J. Pharmacol. 262:1994;41-48.
23. Rittenhouse A.R., Parker C., Brugnara C., Morgan K.G., Alper S.L. Inhibition of maxi-K currents in ferret portal vein smooth muscle cells by the antifungal clotrimazole. Am. J. Physiol. 173:1997;C45-C56.
24. Rittenhouse A.R., Vandorpe D.H., Brugnara C., Alper S.L. The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells. J. Memb. Biol. 157:1997;177-191.
25. + conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. J. Clin. Invest. 100:1997;3111-3120.
26. Sawyer P.R., Brogden R.N., Pinder R.M., Speight T.M., Avery G.S. Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 9:1975;424-447.
27. Sheets J.J., Mason J.I., Wise C.A., Estabrook R.W. Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents. Biochem. Pharmacol. 35:1986;487-491.
28. 3. Am. J. Physiol. 261:1991;E66-E75.
29. Stalla G.K., Stalla J., von Werder K. et al. Nitroimidazole derivatives inhibit anterior pituitary cells function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme. Endocrinology. 125:1989;699-706.
30. + channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J. Biol. Chem. 273:1998;21542-21553.
31. 3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J. 6:1992;2742-2747.
32. Welker S., Drews G. Imidazole antimycotics affect the activity of various ion channels and insulin secretion in mouse pancreatic B-cells. Naunyn-Schmied. Arch. Pharmacol. 356:1997;543-550.
33. + channels by extracellular ATP and UTP in rat atrial myocytes. J. Cardiovasc. Pharmacol. 31:1998;203-211.
34. Wu S.N., Yu H.S., Jan C.R., Li H.F., Yu C.L. Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells. Life Sci. 62:1998;2283-2294.
35. + currents in pulmonary arterial myocytes. Am. J. Physiol. 268:1995;C259-C270.